AbbVie Announces U.S. FDA Approval of EPKINLY® in Combination with Rituximab and Lenalidomide for Relapsed or Refractory Follicular Lymphoma Pharmaceutical Investing
Arrowhead Pharmaceuticals Announces FDA Approval of REDEMPLO® to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome Life Science Investing
Rain Enhancement Technologies Secures Second U.S. Installation with Utah Permit Approval, Advances Snow Enhancement Capabilities Life Science Investing
Sonnet BioTherapeutics Holdings, Inc. Announces Adjournment of Special Meeting Life Science Investing
ABVC BioPharma Receives US$240,000 Licensing Payment From OncoX BioPharma; Total Licensing Payments Reach Approximately US$2.53 Million Life Science Investing
Delcath Systems Announces Publication of Expert Narrative Review on Percutaneous Hepatic Perfusion for Liver Metastases from Uveal Melanoma Life Science Investing
Nextech3D.ai Accelerates Eventdex Integration; Expands AI Matchmaking and Achieves Milestone Production of 800 Interactive Floor Plans in 2025 Artificial Intelligence Investing
InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901 Pharmaceutical Investing
